HomeHRMY • NASDAQ
add
Harmony Biosciences Holdings Inc
Previous close
$34.80
Day range
$34.64 - $35.24
Year range
$26.47 - $41.61
Market cap
2.02B USD
Avg Volume
608.25K
P/E ratio
11.32
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 200.49M | 16.01% |
Operating expense | 114.16M | -4.32% |
Net income | 39.78M | 243.16% |
Net profit margin | 19.84 | 195.68% |
Earnings per share | 0.92 | -12.38% |
EBITDA | 54.15M | 97.56% |
Effective tax rate | 19.87% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 565.27M | 62.95% |
Total assets | — | — |
Total liabilities | 334.93M | 4.73% |
Total equity | — | — |
Shares outstanding | 57.53M | — |
Price to book | 2.59 | — |
Return on assets | 11.13% | — |
Return on capital | 13.06% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 39.78M | 243.16% |
Cash from operations | — | — |
Cash from investing | -19.59M | 64.29% |
Cash from financing | -2.69M | 22.05% |
Net change in cash | 57.05M | 463.74% |
Free cash flow | 44.08M | 528.35% |
About
Founded
2017
Website
Employees
268